Published in Int J Neuropsychopharmacol on December 01, 2002
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer (2008) 3.68
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med (2013) 1.78
Retracted Peripheral cytokines as a chemical mediator for postconcussion like sickness behaviour in trauma and perioperative patients: literature review. Neurol Res Int (2014) 1.39
Molecular and functional properties of P2X receptors--recent progress and persisting challenges. Purinergic Signal (2012) 1.31
Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci (2009) 1.23
Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun (2006) 1.18
Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav (2007) 1.13
Psychophysiological effects of a web-based stress management system: a prospective, randomized controlled intervention study of IT and media workers [ISRCTN54254861]. BMC Public Health (2005) 1.09
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother (2008) 1.08
Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett (2009) 1.07
Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatr Dis Treat (2009) 1.00
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
A final common pathway for depression? Progress toward a general conceptual framework. Neurosci Biobehav Rev (2007) 0.93
On the potential role of glutamate transport in mental fatigue. J Neuroinflammation (2004) 0.83
Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain. Arthritis Res Ther (2010) 0.81
Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination. Brain Behav Immun (2007) 0.80
[Elevated postoperative pain levels following orthopedic surgery. Depression as a strong predictor]. Schmerz (2010) 0.78
Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine. Psychopharmacology (Berl) (2010) 0.78
The Cox-2 Inhibitor Meloxicam Ameliorates Neuroinflammation and Depressive Behavior in Adult Mice after Splenectomy. J Neurophysiol Neurol Disord (2016) 0.75
Body affects mind? Preoperative behavioral and biological predictors for postoperative symptoms in mental health. J Behav Med (2012) 0.75
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration. Front Cell Neurosci (2017) 0.75
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A (2005) 3.83
GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry (2008) 2.04
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.87
Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci (2003) 1.74
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol (2008) 1.61
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci (2009) 1.58
Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci (2007) 1.55
Cytokines, stress and depressive illness: brain-immune interactions. Ann Med (2003) 1.44
Evaluation of the effects of chronic mild stressors on hedonic and physiological responses: sex and strain compared. Brain Res (2003) 1.37
Therapeutic and protective effect of environmental enrichment against psychogenic and neurogenic stress. Behav Brain Res (2006) 1.35
Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des (2005) 1.30
Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci (2008) 1.30
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol (2008) 1.23
Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: Circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav Immun (2008) 1.12
Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl) (2008) 1.05
Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Front Hum Neurosci (2012) 1.03
Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Peptides (2004) 1.02
Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain Behav Immun (2010) 1.01
Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatr Dis Treat (2009) 1.00
Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav Immun (2007) 0.98
Stress, coping, uplifts, and quality of life in subtypes of depression: a conceptual frame and emerging data. J Affect Disord (2002) 0.97
Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav Immun (2002) 0.96
Experiential and genetic contributions to depressive- and anxiety-like disorders: clinical and experimental studies. Neurosci Biobehav Rev (2008) 0.95
Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease. Parkinsons Dis (2010) 0.95
Sensitization associated with stressors and cytokine treatments. Brain Behav Immun (2003) 0.93
Closure of small bowel stomas on postoperative day 10. Eur J Surg (2002) 0.93
Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav Brain Res (2007) 0.92
Psychosocial stress evoked by a virtual audience: relation to neuroendocrine activity. Cyberpsychol Behav (2007) 0.92
Maternal factors and monoamine changes in stress-resilient and susceptible mice: cross-fostering effects. Brain Res (2006) 0.92
Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging (2011) 0.91
Molecular pathway reconstruction and analysis of disturbed gene expression in depressed individuals who died by suicide. PLoS One (2012) 0.91
Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J Neuroimmunol (2007) 0.91
Ethnopharmacology of Q'eqchi' Maya antiepileptic and anxiolytic plants: effects on the GABAergic system. J Ethnopharmacol (2009) 0.90
Soothing the threatened brain: leveraging contact comfort with emotionally focused therapy. PLoS One (2013) 0.90
Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Neurobiol Aging (2008) 0.88
Inflammatory factors contribute to depression and its comorbid conditions. Sci Signal (2012) 0.88
Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior. Behav Brain Res (2007) 0.87
The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms. PLoS One (2013) 0.86
Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: Implications for psychological pathology. Brain Behav Immun (2009) 0.86
Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress (2003) 0.86
Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain. Front Mol Neurosci (2010) 0.84
[Early closure of temporary stoma of the small bowel]. Gastroenterol Clin Biol (2003) 0.83
Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes. PLoS One (2013) 0.83
Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibition. PLoS One (2012) 0.81
Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice. Eur J Neurosci (2008) 0.81
Neurochemical and behavioral responses to inflammatory immune stressors. Front Biosci (Schol Ed) (2009) 0.80
Changes in extracellular levels of amygdala amino acids in genetically fast and slow kindling rat strains. Brain Res (2002) 0.80
The role of gastrin-releasing peptide on conditioned fear: differential cortical and amygdaloid responses in the rat. Psychopharmacology (Berl) (2006) 0.80
Bombesin receptor regulation of emotional memory. Rev Neurosci (2012) 0.80
Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects. J Psychiatry Neurosci (2002) 0.79
Ruminative coping among patients with dysthymia before and after pharmacotherapy. Depress Anxiety (2007) 0.79
Cytokines as potential biomarkers for Parkinson's disease: a multiplex approach. Methods Mol Biol (2012) 0.79
Preferred Features of E-Mental Health Programs for Prevention of Major Depression in Male Workers: Results From a Canadian National Survey. J Med Internet Res (2016) 0.78
Synaptic neurotransmission depression in ventral tegmental dopamine neurons and cannabinoid-associated addictive learning. PLoS One (2010) 0.78
Amygdala amino acid and monoamine levels in genetically Fast and Slow kindling rat strains during massed amygdala kindling: a microdialysis study. Eur J Neurosci (2004) 0.78
Differential impact of audiogenic stressors on Lewis and Fischer rats: behavioral, neurochemical, and endocrine variations. Neuropsychopharmacology (2003) 0.78
Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat. Psychopharmacology (Berl) (2008) 0.78
Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice. Neuroimmunomodulation (2004) 0.77
The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice. Neurosci Lett (2011) 0.77
Ethnopharmacological investigation of plants used to treat susto, a folk illness. J Ethnopharmacol (2006) 0.77
Anxiety in rats selectively bred for Fast and Slow kindling rates: situation-specific outcomes. Stress (2003) 0.77
Viral-toxin interactions and Parkinson's disease: poly I:C priming enhanced the neurodegenerative effects of paraquat. J Neuroinflammation (2012) 0.77
Effects of acute or chronic omega-3 and omega-6 polyunsaturated fatty acid treatment on behavioral, neuroendocrine and cytokine changes elicited by exogenous interleukin-1beta challenge. J Neuroimmunol (2006) 0.77
Neurotrophic paths in the treatment of depression. J Psychiatry Neurosci (2013) 0.77
In vivo levels of corticotropin-releasing hormone and gastrin-releasing peptide at the basolateral amygdala and medial prefrontal cortex in response to conditioned fear in the rat. Neuropharmacology (2010) 0.76
Hypoxia alters the expression of inhibitor of apoptosis proteins after brain trauma in the mouse. J Neurotrauma (2007) 0.76
Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets? CNS Neurol Disord Drug Targets (2014) 0.76
A comment on the role of environmental factors in Parkinson's disease. Can J Neurol Sci (2010) 0.75
Illness comorbidity as a biomarker? J Psychiatry Neurosci (2012) 0.75
A refined blood collection method for quantifying corticosterone. Lab Anim (NY) (2012) 0.75
Anxiolytic activity of a supercritical carbon dioxide extract of Souroubea sympetala (Marcgraviaceae). Phytother Res (2011) 0.75
Characterization of the anxiolytic activity of Nunavik Rhodiola rosea. Planta Med (2013) 0.75
Souroubea sympetala (Marcgraviaceae): a medicinal plant that exerts anxiolysis through interaction with the GABAA benzodiazepine receptor. Can J Physiol Pharmacol (2014) 0.75
Neurochemical sensitization associated with systemic administration of tumor necrosis factor-alpha: adjuvant action in combination with bovine serum albumin. J Neuroimmunol (2003) 0.75